Recruitment of Labelled Monocytes by Experimental Venous Thrombi

Summary

Objective. Infusing monocytes that have been stimulated to produce fibrinolytic activators and factors that regulate cell proliferation, migration and maturation, might enhance venous thrombus resolution. The aim of this study was to determine the time course of infused monocyte recruitment into venous thrombus in an appropriate model of this disease. Design and Methods. Thrombus was induced in the inferior vena cava of male Wistar rats using reduced flow (80-90% stenosis). The vessel wall was examined at 1hr by scanning electron microscopy. Resolving thrombi with surrounding vena cava were obtained at 1, 7, 14 and 21 days after induction (n = 8). Sections, taken at 0.5 mm intervals (10-15 sections per thrombus), were stained using haematoxylin, Martius Scarlet Blue and antibodies against monocytes, platelets and fibrin. Sections from human venous thrombi (n = 4) were similarly stained. The area occupied by monocytes (in relative pixel units, RPU) was determined using computer aided image analysis. Peripheral rat blood monocytes were extracted, fluorescently labelled and injected intravenously into 7 rats prior to thrombus induction. Vena cava with thrombus was harvested 1 h, 2, 3, 4, 7, 14 and 25 days after induction and their fluorescence measured. The fluorescent content of the caval wall and thrombus was analysed in greater detail at 2 and 25 days after thrombus induction (n = 4 at each time interval). Results. Experimental thrombi were structurally similar to human thrombus and resolved within 14-21 days. Scanning electron microscopy showed minimal endothelial damage at 1 h with signs of early thrombus formation (platelet, red cell leukocyte and fibrin deposition). Neutrophils were the predominant leukocyte in the thrombus at 1 day, with monocytes making up only 0.3% (0.04% sem) of the area of the thrombus. There was a steady increase in thrombus monocyte content and by 21 days the percentage area of thrombus covered by monocytes had increased by over 35 fold to 11.5% (2.3% sem) (p <0.001). Initially, monocytes appeared around the edge of the thrombus and became more evenly distributed through the thrombus as resolution progressed. Labelled monocytes could be found in the circulation up to 1 week after infusion. The fluorescent content (RPU) of the thrombus increased over 25 days (mean RPU At 2 days 0.012, sem 0.005; mean RPU at 25 days 1.062, sem 0.252, p = 0.008). The number of labelled monocytes in the vessel wall peaked at 2 days and decreased thereafter.

Key words

Venous - thrombosis - monocyte

• References

• 1 Rohovsky S, D’Amore PA. Growth factors and angiogenesis in wound healing. In Zeigler TR, Pierce GF, Herndon DN. Eds. Growth factors and wound healing. New York: Springer; 1997
• 2 Leibovich SJ, Weisman DM. Macrophages, wound repair and angiogenesis. Prog Clin Biol Res 1998; 266: 131-45.
• 3 Wakefield TW, Strieter RM, Wilke CA, Kadell AM, Wrobleski SK, Burdick MD, Schmidt R, Kunkel SL, Greenfield LJ. Venous thrombosis – associated inflammation and attenuation with neutralising antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 258-68.
• 4 Wakefield TW, Linn MJ, Henke PK, Kadell AM, Wilke CA, Wrobleski SK, Sarkar M, Myers DD, Strieter RM. Neovascularisation during venous thrombus organisation: A preliminary study. J Vasc Surg 1999; 30: 885-93.
• 5 Northeast ADR, Soo KS, Bobrow LG, Gaffney PJ, Burnand KG. The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus. J Vasc Surg 1995; 22: 573-9.
• 6 Soo KS, Northeast ADR, Happerfield LC, Burnand KG, Boborow LG. Tissue plasminogen activator production by monocytes in venous thrombolysis. J Pathol 1996; 178: 190-4.
• 7 Simon DI, Ezratty AM, Francis SA. et al. Fibrinogen is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a non-plasmin fibrinolytic pathway. Blood 1993; 82: 2414-22.
• 8 Humphries J, McGuinness C, Smith A, Waltham M, Collins M, Burnand K. MCP-1 accelerates the organisation and resolution of venous thrombi. J Vasc Surg 1999; 30: 894-900.
• 9 Kwaan HC, Grumet G. Clinical use of 51Cr-leukocytes in the detection of DVT. Circulation 1971; 44 (S2) 55.
• 10 Humphries J, McGuinness CL, Smith A, Waltham M, Poston R, Burnand KG. Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J Vasc Surg 1999; 30: 890-4.
• 11 Andreesen R, Scheibenbogan C, Brugger W. et al. A new approach to adoptive immunotherapy of cancer using tumorocytic macrophages grown from peripheral blood monocytes. Cancer Detection and Prevention 1991; 15: 413-21.
• 12 Cox JST. The maturation and canalisation of thrombi. Surg Gynec and Obstet 1963; 116: 593-9.
• 13 Sevitt S. The mechanisms of canalisation in deep vein thrombosis. J Path 1973; 110: 153-65.
• 14 Melnicoff MJ, Morahan BD, Jensen EW, Horan PK. In vivo labelling of peritoneal macropahges. J. Leuckocyte Bilogy 1998; 43: 387-97.
• 15 Teare GF, Horan PK, Slezak SE, Smith C, Hay JB. Long term tracking of lymphocytes in vivo: The miogration of PKH labelled lymphocytes. Cellular Immunology 1991; 134: 157-70.
• 16 Issekutz TB, Issekutz AC, Movat HZ. The in vivo quantitation and kinetics of monocyte migration into acute inflammatory tissue. Am J Pathol 1981; 103: 47-55.
• 17 Valente AJ, Rozek MM, Sprague EA, Scwartz CJ. Mechanisms in intimal monocyte-macrophage recruitment. Circ 1992; 86: III20-III25.
• 18 Ozawa M, Terui T, Tanita M, Kato T, Tagami H. Release of monocyte chemoattractants by polymorphonuclear leukocytes stimulated by their adhesion to stratum corneum opsonized via complement activation, measured with a human acute monocytic leukemic cell line, THP-1. Exp Dermatol 1998; 7: 151-6.
• 19 Scapini P, Calzetti F. Cassatella MA On the detection of neutrophil-derived vascular endothelial growth factor (VEGF). J Immunol Methods 1999; 232: 121-9.
• 20 Yamashiro S, Kamohara H, Yoshimura T. MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression. J Leukocyte Biol 1999; 65: 671-9.
• 21 Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherosclerosis. Proc Natl Acad Sci USA 1988; 85: 2805-8.
• 22 Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migration of human monocytes in response to VEGF is mediated via the VEGF receptor flt-1. Blood 1996; 87: 3336-43.
• 23 Waltham M, Collins M, Burnand KG, Smith A. VEGF and bFGF are found in resolving venous thrombi. J Vasc Surg. 2000 In Press.
• 24 Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995; 1: 27-31.
• 25 Newman KM, Jean-Claude J, Li H. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 1994; 20: 814-20.
• 26 Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE. Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 1993; 18: 596-605.
• 27 Kakkar VV, Lawrence D. Haemodynamic and clinical assessment after therapy for acute deep vein thrombosis, a prospective study. Am J Surg 1985; 150: 54-63.
• 28 Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analysis of randomised trials of streptokinase and heparin in phlebographically documented acute deep vein thrombosis. Am J Med 1984; 76: 393-7.